Ondansetron: uses, dosing, side effects & brands

The label says published studies on ondansetron and major birth defects have reported inconsistent findings and have important methodological limitations that preclude conclusions about its safety in pregnancy. It notes some studies found a possible association with cardiac septal defects or oral clefts (with oral, not IV, ondansetron) while others did not confirm this, and available postmarketing data have not identified a drug-associated risk of miscarriage or adverse maternal outcomes. Animal studies showed no fetal harm at exposures several times the human dose. The label does not tell patients to take or stop the drug; anyone who is or may become pregnant should discuss it with their prescriber. This is what ondansetron's FDA label says; whether to use it in pregnancy is your prescriber's decision.

The elimination half-life of ondansetron is about 3 to 5 hours (roughly 4 hours) in healthy adults — that is how long the body takes to clear half of a dose. Not a prodrug. Ondansetron has some nonconjugated metabolites with pharmacologic activity, but the label states they are not present in plasma at concentrations likely to significantly contribute to its effect, so no active metabolite meaningfully outlasts the parent. Half-life lengthens with age (increase seen in patients over 75, to roughly 5-6 hours) and especially with liver disease: mean half-life rises to about 11.6 hours in mild-to-moderate hepatic impairment and to about 20 hours in severe hepatic impairment (Child-Pugh 10+). In severe renal impairment (CrCl under 30 mL/min) mean plasma clearance falls about 50%, though the label gives no specific half-life. Rule of thumb: it takes roughly 4-5 half-lives (about a day in a healthy adult) to clear the drug from the body. Half-life is not the same as how long a drug test can detect the drug, and it varies with age, kidney and liver function.

It depends on the medicine. We check it against the FDA labels rather than guessing: our interaction checker searches each drug's own label for the other and quotes what it says, naming the section it came from. Run ondansetron against whatever else you take — and remember that a label not naming a drug is not the same as that combination being safe.

We track 7 ondansetron-containing products in the U.S.: Ondansetron Hydrochloride, Zofran and Dextrose in Plastic Container, Zofran, Zofran ODT, Zofran Preservative Free, Ondansetron and Zuplenz. They are the same active ingredient; they differ in form, manufacturer, price and FDA recall record.

Across the brands we track, ondansetron is currently marketed as solution, injectable, tablet, tablet, orally disintegrating and film, per the FDA's National Drug Code Directory. Each form is dosed differently — follow the label for the exact product you were prescribed.

Yes. Our catalog lists 2 generic ondansetron products alongside the brand versions. A generic has the same active ingredient and must meet the FDA's bioequivalence standard; it usually costs less. Ask your pharmacist which one your plan covers.

The FDA's Enforcement database lists 2 recall records whose product description mentions ondansetron. The most recent: Ondansetron Orally Disintegrating Tablets (Dec 30, 2025). A recall applies to specific lots, not to the drug as a whole — check the record for the affected lot numbers.

The most common are headache, constipation, tiredness, and dizziness. Some people notice a warm or flushed feeling. These are usually mild; constipation is worth managing with fluids and fiber, since ondansetron slows the gut and can occasionally mask a serious blockage.

Yes. Ondansetron can prolong the QT interval, a change in the heart's electrical timing that can rarely trigger a dangerous rhythm called Torsades de pointes. The risk is higher with larger doses, with low blood potassium or magnesium, and when combined with other QT-prolonging drugs. Because of this, a single 32 mg intravenous dose was withdrawn. Seek care for fainting, palpitations, or an irregular heartbeat.

Ondansetron affects serotonin signaling and can contribute to serotonin syndrome, especially when combined with other serotonergic drugs such as certain antidepressants (SSRIs, SNRIs) or migraine triptans. Get emergency care for agitation, confusion, fast heartbeat, fever, sweating, muscle twitching or stiffness, tremor, or loss of coordination.

Headache, constipation, and mild tiredness are expected and usually manageable. Seek urgent care for fainting or an irregular or racing heartbeat, the cluster of symptoms suggesting serotonin syndrome, or signs of a serious allergic reaction such as rash, swelling of the face or throat, or trouble breathing. Also tell your doctor if severe constipation, bloating, or belly pain develops, since ondansetron can hide the symptoms of a bowel obstruction.

Ondansetron (brand Zofran) is FDA-approved to prevent nausea and vomiting caused by cancer chemotherapy, radiation therapy, and surgery (anesthesia). It works by blocking serotonin (5-HT3) signals that trigger the vomiting reflex. It is used to prevent nausea rather than as a general treatment for an already-upset stomach.

Yes. Doctors frequently prescribe ondansetron off-label for nausea and vomiting from stomach bugs (gastroenteritis) and, more controversially, for severe morning sickness in pregnancy. These are not FDA-approved uses. Pregnancy use in particular is debated and should only be done under a doctor's guidance.

The most important one is a heart-rhythm change called QT prolongation, especially at higher doses or in people with existing heart-rhythm problems or low potassium/magnesium. Common milder side effects include headache, constipation, and tiredness. Tell your doctor about any heart conditions before using it.